Table of Content


Chapter 1. Global Herpes Infection Treatment Market Executive Summary
1.1. Global Herpes Infection Treatment Market Size & Forecast (2022–2032)
1.2. Regional Summary
1.3. Segmental Summary
?1.3.1. By Type
?1.3.2. By Drug
?1.3.3. By Vaccine
?1.3.4. By Route of Administration
?1.3.5. By End-use
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Herpes Infection Treatment Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
?2.3.1. Inclusion & Exclusion
?2.3.2. Limitations
?2.3.3. Supply Side Analysis
??2.3.3.1. Availability
??2.3.3.2. Infrastructure
??2.3.3.3. Regulatory Environment
??2.3.3.4. Market Competition
??2.3.3.5. Economic Viability (Consumer’s Perspective)
?2.3.4. Demand Side Analysis
??2.3.4.1. Regulatory Frameworks
??2.3.4.2. Technological Advancements
??2.3.4.3. Environmental Considerations
??2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Herpes Infection Treatment Market Dynamics
3.1. Market Drivers
?3.1.1. Rising HSV-1 and HSV-2 Prevalence
?3.1.2. Growing Adoption of Antiviral Prophylaxis
?3.1.3. Increased R&D in Vaccine Development
3.2. Market Challenges
?3.2.1. Viral Mutability and Resistance
?3.2.2. Regulatory Delays and Trial Setbacks
3.3. Market Opportunities
?3.3.1. Emergence of Simplirix and Next-Gen Vaccines
?3.3.2. Digital Health and Telemedicine in HSV Care
?3.3.3. CRISPR and RNA-Based Therapeutic Platforms
Chapter 4. Global Herpes Infection Treatment Market Industry Analysis
4.1. Porter’s Five Forces Model
?4.1.1. Bargaining Power of Suppliers
?4.1.2. Bargaining Power of Buyers
?4.1.3. Threat of New Entrants
?4.1.4. Threat of Substitutes
?4.1.5. Competitive Rivalry
?4.1.6. Futuristic Adaptation of Porter’s Model
?4.1.7. Porter’s Five Forces Impact Analysis
4.2. PESTEL Analysis
?4.2.1. Political
?4.2.2. Economic
?4.2.3. Social
?4.2.4. Technological
?4.2.5. Environmental
?4.2.6. Legal
4.3. Top Investment Opportunities
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspectives
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Herpes Infection Treatment Market Size & Forecasts by Type (2022–2032)
5.1. Segment Dashboard
5.2. HSV-1: Revenue Trend Analysis, 2022 & 2032 (USD Million)
5.3. HSV-2: Revenue Trend Analysis, 2022 & 2032 (USD Million)
Chapter 6. Global Herpes Infection Treatment Market Size & Forecasts by Drug (2022–2032)
6.1. Segment Dashboard
6.2. Acyclovir: Revenue Trend Analysis, 2022 & 2032 (USD Million)
6.3. Valacyclovir: Revenue Trend Analysis, 2022 & 2032 (USD Million)
6.4. Famciclovir: Revenue Trend Analysis, 2022 & 2032 (USD Million)
Chapter 7. Global Herpes Infection Treatment Market Size & Forecasts by Vaccine (2022–2032)
7.1. Segment Dashboard
7.2. Simplirix: Revenue Trend Analysis, 2022 & 2032 (USD Million)
7.3. Others: Revenue Trend Analysis, 2022 & 2032 (USD Million)
Chapter 8. Global Herpes Infection Treatment Market Size & Forecasts by Route of Administration (2022–2032)
8.1. Segment Dashboard
8.2. Oral: Revenue Trend Analysis, 2022 & 2032 (USD Million)
8.3. Topical: Revenue Trend Analysis, 2022 & 2032 (USD Million)
8.4. Injectable: Revenue Trend Analysis, 2022 & 2032 (USD Million)
Chapter 9. Global Herpes Infection Treatment Market Size & Forecasts by End-use (2022–2032)
9.1. Segment Dashboard
9.2. Hospitals: Revenue Trend Analysis, 2022 & 2032 (USD Million)
9.3. Clinics: Revenue Trend Analysis, 2022 & 2032 (USD Million)
9.4. Retail Pharmacies: Revenue Trend Analysis, 2022 & 2032 (USD Million)
9.5. Online Providers: Revenue Trend Analysis, 2022 & 2032 (USD Million)
Chapter 10. Global Herpes Infection Treatment Market Size & Forecasts by Region (2022–2032)
10.1. North America Market
?10.1.1. U.S. Market
?10.1.2. Canada Market
10.2. Europe Market
?10.2.1. UK Market
?10.2.2. Germany Market
?10.2.3. France Market
?10.2.4. Spain Market
?10.2.5. Italy Market
?10.2.6. Rest of Europe Market
10.3. Asia Pacific Market
?10.3.1. China Market
?10.3.2. India Market
?10.3.3. Japan Market
?10.3.4. Australia Market
?10.3.5. South Korea Market
?10.3.6. Rest of Asia Pacific Market
10.4. Latin America Market
?10.4.1. Brazil Market
?10.4.2. Mexico Market
10.5. Middle East & Africa Market
?10.5.1. Saudi Arabia Market
?10.5.2. South Africa Market
?10.5.3. Rest of Middle East & Africa Market
Chapter 11. Competitive Intelligence
11.1. Key Company SWOT Analysis
?11.1.1. Pfizer Inc.
?11.1.2. GlaxoSmithKline plc
?11.1.3. Novartis AG
11.2. Top Market Strategies
11.3. Company Profiles
?11.3.1. Pfizer Inc.
??11.3.1.1. Key Information
??11.3.1.2. Overview
??11.3.1.3. Financial (Subject to Data Availability)
??11.3.1.4. Product Summary
??11.3.1.5. Market Strategies
?11.3.2. Teva Pharmaceutical Industries Ltd.
?11.3.3. Sanofi S.A.
?11.3.4. Cipla Inc.
?11.3.5. Aurobindo Pharma
?11.3.6. Mylan N.V.
?11.3.7. Alembic Pharmaceuticals
?11.3.8. Viatris Inc.
?11.3.9. Sun Pharmaceutical Industries Ltd.
?11.3.10. Dr. Reddy’s Laboratories Ltd.
?11.3.11. Biovista
?11.3.12. Avet Pharmaceuticals
?11.3.13. AiCuris Anti-infective Cures AG
Chapter 12. Research Process
12.1. Research Process
?12.1.1. Data Mining
?12.1.2. Analysis
?12.1.3. Market Estimation
?12.1.4. Validation
?12.1.5. Publishing
12.2. Research Attributes



List of Figures

List of Figures
FIG 1. Global Herpes Infection Treatment market, research methodology
FIG 2. Global market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global market, key trends 2023
FIG 5. Global market, growth prospects 2022–2032
FIG 6. Porter’s Five Forces model
FIG 7. PESTEL analysis
FIG 8. Value chain analysis
FIG 9. Market by Type, 2022 & 2032 (USD Million)
FIG 10. Market by Drug, 2022 & 2032 (USD Million)
FIG 11. Market by Vaccine, 2022 & 2032 (USD Million)
FIG 12. Market by Route of Administration, 2022 & 2032 (USD Million)
FIG 13. Market by End-use, 2022 & 2032 (USD Million)
FIG 14. Regional snapshot 2022 & 2032
FIG 15. North America market 2022 & 2032 (USD Million)
FIG 16. Europe market 2022 & 2032 (USD Million)
FIG 17. Asia Pacific market 2022 & 2032 (USD Million)
FIG 18. Latin America market 2022 & 2032 (USD Million)
FIG 19. Middle East & Africa market 2022 & 2032 (USD Million)
FIG 20. Vaccine development & AI diagnostics trends (2023)

List of Tables

List of Tables
TABLE 1. Global Herpes Infection Treatment market, report scope
TABLE 2. Global Herpes Infection Treatment market estimates & forecasts by Region 2022–2032 (USD Million)
TABLE 3. Global Herpes Infection Treatment market estimates & forecasts by Type 2022–2032 (USD Million)
TABLE 4. Global Herpes Infection Treatment market estimates & forecasts by Drug 2022–2032 (USD Million)
TABLE 5. Global Herpes Infection Treatment market estimates & forecasts by Vaccine 2022–2032 (USD Million)
TABLE 6. Global Herpes Infection Treatment market estimates & forecasts by Route of Administration 2022–2032 (USD Million)
TABLE 7. Global Herpes Infection Treatment market estimates & forecasts by End-use 2022–2032 (USD Million)
TABLE 8. Global Herpes Infection Treatment market by segment, estimates & forecasts, 2022–2032 (USD Million)
TABLE 9. U.S. Herpes Infection Treatment market estimates & forecasts, 2022–2032 (USD Million)
TABLE 10. U.S. market estimates & forecasts by segment 2022–2032 (USD Million)
TABLE 11. Canada market estimates & forecasts, 2022–2032 (USD Million)
TABLE 12. Canada market estimates & forecasts by segment 2022–2032 (USD Million)
TABLE 13. UK market estimates & forecasts, 2022–2032 (USD Million)
TABLE 14. Germany market estimates & forecasts, 2022–2032 (USD Million)
TABLE 15. France market estimates & forecasts, 2022–2032 (USD Million)
TABLE 16. Spain market estimates & forecasts, 2022–2032 (USD Million)
TABLE 17. Italy market estimates & forecasts, 2022–2032 (USD Million)
TABLE 18. Asia Pacific market estimates & forecasts, 2022–2032 (USD Million)
TABLE 19. Latin America market estimates & forecasts, 2022–2032 (USD Million)
TABLE 20. Middle East & Africa market estimates & forecasts, 2022–2032 (USD Million)